Charles B. Klein
Chuck is a first-chair trial lawyer with almost 30 years of experience who litigates significant patent, antitrust, and commercial disputes. He is the litigation office head in Washington, D.C. and was a longtime member of the firm’s Executive Committee, co-chaired the firm’s Intellectual Property Practice, and chaired the firm’s Commercial Litigation Practice. IAM, which ranks him in the Gold tier, described him as a “talisman for major pharmaceutical and biotechnology businesses” who is “no stranger to billion-dollar cases.” Managing Intellectual Property likewise recognized him as an “IP Star.” Seven of Chuck’s first-chair victories (including three trial wins) have been mentioned in the “Litigator of the Week” column published by The American Lawyer.
Key Matters
Select examples of Chuck’s representative experience include:
- As lead trial and appellate counsel, obtained a trial judgment, affirmed on appeal, of noninfringement related to a stress-test agent.
- As lead trial and appellate counsel, obtained a trial judgment, affirmed on appeal, invalidating six patents related to a drug used to treat very high triglyceride levels.
- As lead trial and appellate counsel, obtained a trial judgment, affirmed on appeal, invalidating four patents related to a multiple sclerosis drug.
- As lead trial and appellate counsel, convinced the Federal and D.C. Circuits to deny requests for injunctive relief related to a drug that treats gout.
- As lead trial counsel, obtained a trial judgment of non-infringement and invalidity regarding an insomnia drug.
- Obtained the first injunction under the Hatch-Waxman counterclaim provision—a significant ruling for the generic-drug industry that the Supreme Court ultimately upheld in a 9–0 decision.
- Obtained a defense jury verdict in a US$1.7B pharmaceutical antitrust case identified by The Daily Journal as one of the “Top Verdicts of 2011.”
A biotechnology and pharmaceutical ace who continues to achieve excellent results...
IAM Patent 1000